Table 3 Abnormal measures of thrombophilia and hypofibrinolysis in 24 women who used hormone replacement therapy on estrogen-progestin oral contraceptives before pulmonary embolism (18 women had coagulation measures)
Factor V | PTG | Factor VIII | Factor XI | ACLA IgG | ACLA IgM | Lupus anticoagulant | Pro S | Free S | Anti III | |
|---|---|---|---|---|---|---|---|---|---|---|
Abnormal range | TC/TT | TC/TT | > 150 % | > 150 % | Dated cut pointa | Y | < 63 % | < 66 % | < 80 % | |
ID# 1 | 78 | |||||||||
3 | 20.0 | |||||||||
4 | ||||||||||
5 | TC | 47 | ||||||||
6 | 70 | |||||||||
8 | TC | |||||||||
9 | Y | 71 | ||||||||
10 | 212 | |||||||||
11 | Y | |||||||||
12 | 61 | |||||||||
13 | 16.0 | 59 | ||||||||
14 | ||||||||||
15 | 301 | 151 | 17.0 | 39 | ||||||
17 | TC | |||||||||
18 | 48 | |||||||||
22 | TC | |||||||||
24 | TC | |||||||||